TickerFacts.

Solventum Corp (SOLV): Gross Profit

Annual figures by period end, from SEC filings.

$4.45B
Year ended 2025-12-31
$4.54B
Trailing 12 months to 2026-06-30
-1.8%
3-year compound annual growth
$4.70B2022-12-31: $4.70B2023-12-31: $4.69B2024-12-31: $4.59B2025-12-31: $4.45B$4.45B
2022-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$4.45B-3.1%2026-02-27, From 2025-01-01
2024-12-31$4.59B-2.1%2026-02-27, From 2024-01-01
2023-12-31$4.69B0.0%2026-02-27, From 2023-01-01
2022-12-31$4.70Bn/a2025-02-28, From 2022-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Solventum Corp (SOLV)2025-12-31$4.45B-3.1%
Baxter International Inc (BAX)2025-12-31$3.38B-15.2%
ResMed Inc (RMD)2026-06-30$3.45B+13.0%
Dexcom Inc (DXCM)2025-12-31$2.80B+14.9%
Boston Scientific Corp (BSX)2025-12-31$13.85B+20.6%
Becton Dickinson & Co (BDX)2025-09-30$9.93B+8.8%
MiniMed Group, Inc. (MMED)2026-04-24$1.68B+9.9%
West Pharmaceutical Services Inc (WST)2025-12-31$1.10B+10.6%
Globus Medical Inc (GMED)2025-12-31$1.98B+33.5%

Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗